How to provide a third party with the authority to undertake licensable activities on behalf of a licensed establishment
This section explains the consent exemptions from the Human Tissue Act (2004)
Guidance on paragraphs 194-196: HTA’s Code of Practice on the Human Transplantation (Wales) Act 2013
Guidance on paragraphs 194-196 of the HTA’s Code of Practice on the Human Transplantation (Wales) Act 2013 - Persons who Lack Capacity to Consent
HTA position on biological testing requirements for autologous donors of tissues and cells.
New EU regulations for medical devices (MDR) and in-vitro medical devices (IVDR) have been introduced. These regulations entered into force on 25 May 2017 across EU Member States. However, most requirements will not fully apply until 26 May 2020 for the MDR, and 26 May 2022 for the IVDR.The scope of the MDR now includes certain products manufactured utilising derivatives of tissues or cells of...
Information for regional resilience teams on licensing of emergency mortuaries.
The transportation and delivery of tissues or cells intended for human application, including to or from other countries
Position statement jointly produced and issued by the Human Tissue Authority (HTA) and the Health Research Authority (HRA).
Regulation regarding cells procured from a person and processed during a single surgical procedure
Position statement on extending existing licences to cover the removal of tissue from the deceased for research